Poverty remains the world's biggest health problem, underlying the HIV/AIDS crisis, the high mortality attributed to tuberculosis and malaria, and the 30 000 deaths of children every day from preventable and treatable causes. It also results in governments being unable to foster socioeconomic development and invest in eff ective health, welfare, and education systems.
Frequent references are made to the World Bank calculation that the number and proportion of people living on less than US$1 per day has fallen since the late 1980s. However, less is said about this calculation's systematic underestimation of the extent of impoverishment. 4 When a more appropriate $2 per day income threshold is used, even by the World Bank's calculations the number of people living in poverty increased between 1981 and 2001 to about 2·7 billion people. 5 This growth in poverty has been accompanied by a growth in wealth. While the number of people living in poverty in sub-Saharan Africa increased from 289 million to 514 million between 1981 and 2001, the world's gross domestic product (GDP) increased by US$18 691 billion. 6 40% of the world's poorest people account for 5% of global income, while the richest 10%, mostly in high-income countries, account for 54%. 7 Generation of wealth is supposed to lead to alleviation of poverty, but has disproportionately benefi ted a minority of the world's population while impoverishing others. According to the World Commission on the Social Dimensions of Globalisation, the governance of the global economy is "prejudicial to the interests of most developing countries, especially the poor within them". 8 The deregulation of fi nance, the global property rights regime, and a winner-takes-all liberalisation of trade are aspects of a form of globalisation that traps many countries and households in poverty. Despite slow increases in development assistance and some debt cancellation, net fl ow of resources from poor to rich countries still work against global health challenges. 9 Although some would argue that issues such as trade and global fi nancial markets fall outside the remit of WHO, we believe that WHO should advocate changes to the macroeconomic and political determinants of ill health if we are to reduce child and maternal mortality, achieve universal access to antiretroviral treatment, and allow all countries to pay their health-care workforce an adequate living wage. Although interventions can be implemented by Ministries of Health to tackle the health-worker crisis, changes to macroeconomic policies will be needed in many countries to increase health-sector spending. WHO could promote comprehensive assessments of global, regional, and bilateral trade agreements for eff ects on health and health systems, and develop a well-resourced unit to carry out such work. As it becomes evident that the growth-led concept of poverty eradication is untenable without an explicit redistribution strategy, 6 WHO must demand further discussion about establishment of new, stable, and sustainable sources of global public fi nancing for health-such as the airline levy introduced by France, which is estimated to be capable of raising about €200 million per year for health. 10 Others have suggested that attention be focused on the development of an international system to reduce tax evasion, which results in an estimated US$350 billion being lost from public accounts. 11 The launch of a Commission on the Social Determinants of Health in March, 2005, off ers hope that WHO would become more active in assessing the health eff ects of the structures and rules of the global political economy. However, WHO's new Director-General must push the Commission to go beyond assessment and propose what WHO can do to engage with economic and social policy.
The new Director-General should also make human rights a pillar of WHO's work-for example, by giving visible and tangible support to the work of the UN's Special Rapporteur on the Right to Health. However, WHO will need to elaborate its human rights principles to stress the transnational obligations and duties of rich countries' governments, international fi nance institutions, individuals, and private corporations towards citizens of developing countries, and emphasise the human rights transgressions that result from global rules and systems that cause or perpetuate poverty.
Development and rehabilitation of national health-care systems
The past few decades have seen many health-care systems become weak to the point of collapse, disintegrated, more inequitable, and increasingly commercialised. 12 Under Lee, WHO began to reassert its commitment to the principles of the Alma Ata Declaration. It now needs to commit to health-systems development policies that are consonant with the Declaration.
This aim should incorporate an evidence-based challenge to prevailing neoliberal reforms of the health sector, coupled with a coherent agenda to strengthen the capacity of Ministries of Health and public health-care systems. The former would require WHO to assist countries to introduce reforms aimed at integrating fragmented pools of public and private health-care fi nance, reversing commercialisation, and shaping the private sector to meet social health objectives. The latter would call for WHO to strengthen its own health-systems departments and develop the public management expertise needed to provide eff ective support to Ministries of Health.
Additionally, WHO must help to bring order to the chaotic proliferation of global health initiatives, many of which are characterised by selective vertical health programmes within countries. This problem has undermined not only WHO, but also Ministries of Health and coherent health-systems planning, by multiplying the number of donor-related conditionalities, increasing the transaction costs associated with having to liaise with several stakeholders, and accentuating the fragmentation of health-care systems.
Another practical step would be to resurrect the 2000 World Health Report initiative to measure and collate health-care system indicators country by country. Although the report had serious conceptual and methodological weaknesses, the underlying idea remains relevant and would enable better monitoring of progressive fi nancing and equitable expenditure for health care, and ascertain whether governments are investing an adequate proportion of public revenue to health.
Protecting people from the hazard merchants
WHO's role in responding to severe acute respiratory syndrome, coordinating preparations for an avian fl u epidemic, and establishing international health regulations to assist control of disease outbreaks demonstrates its importance as a global public-health agency. Its part in helping to formulate evidence-based guidelines and standards on clinical and public-health practice are another valuable role. The new Director-General must continue to strengthen these core functions of WHO.
The challenge of protecting people from non-biological hazards, including commercial activity, should also be emphasised. The International Code of Marketing of Breastmilk Substitutes and the Framework Convention on Tobacco Control are examples of partly positive outcomes of struggles between public health and powerful corporate actors. 13 The connections between commercially generated hazards, those who promote these hazards, and ill-health are both direct and indirect. For example, oil extraction can have direct negative eff ects on the health of surrounding communities as a result of environmental pollution, and is also a global industry that has undermined the science of climate change and retarded action to reduce carbon emissions, to the detriment of health. The automobile industry has successfully lobbied against sensible action to reduce the direct and indirect negative eff ects of current transport and travel patterns on health.
Pharmaceutical corporations are rarely referred to as hazard merchants. However, the Agreement on Trade-Related Aspects of Intellectual Property Rights, which was conceived and brokered largely by Big Pharma working through the offi cial delegations of the USA, Japan, and European Union at the World Trade Organisation, 14 has reduced aff ordability and availability of many medicines and entrenched an intellectual property regime that is ineffi cient at encouraging pharmaceutical research and development, unconducive to safe and ethical practice, and incapable of addressing the needs of poor patients. 15 Regional and bilateral trade agreements are further expanding the cope for unsafe and unethical practice by reducing the capacity to regulate marketing and sale of medicines. 16 Relations between governments, the corporate sector, and citizens have become increasingly unequal, accentuated by globalisation and the accompanying abridgement of national sovereignty and democratic accountability. The relative weakness of public-health institutions is illustrated by the 2004 Global Strategy on Diet, Physical Activity and Health, which was toned down because of opposition from the food and beverages industry (whose fi nancial resources far exceed those of WHO and whose interests were strongly represented by US representatives at WHO). 17 One of WHO's challenges will be to help correct the current imbalance between the liberal, pro-market economic dimension of globalisation with a public safety and social dimension.
Barriers to a more eff ective WHO
A key priority for WHO is an organisational development strategy for itself. Several challenges stand out. One is the need to strengthen WHO's regional and country offi ces, particularly in sub-Saharan Africa, a region that demands the best that WHO can off er. 18 Under Lee, resources shifted from Geneva to the periphery, 19 but some WHO regional and country offi ces do not have the capacity to put increased resources to good use.
This problem is especially acute in poor countries and regions where actors from the UN, donors, nongovernmental organisations, and the research community compete with each other for scarce resources and attention from the Ministry. Rather than providing a focus for improved coordination and integrated leadership, WHO offi ces in Africa can appear as small-time players in the fi eld.
To rectify this problem, WHO needs to clarify the strategic functions and activities of its regional and country offi ces and then recruit (without eroding the skills base of local public and non-government organisations) and retain staff with the appropriate experience and competencies. It should initiate public discussions of its regional and country plans as a mechanism to strengthen public support and public monitoring of its performance.
The Lancet has commented that too many of WHO's programmes are inadequately appraised and allowed to perform suboptimally. However, WHO is not alone in this criticism. Many of its outputs and eff ects have been relatively cost-eff ective and impressive. However, The Lancet hits the nail on the head in calling for WHO "to act systematically as an accountability instrument for the work of other institutions" including the World Bank, the Global Fund to fi ght AIDS, TB and Malaria, and the US president's Emergency Plan for AIDS Relief. 1 Perhaps WHO can raise the bar for improving transparency and independent monitoring of key international agencies involved in promoting health by funding and encouraging academic and non-government organisations to act as critical friends, capable of simultaneously monitoring and supporting the performance of WHO in a transparent manner. WHO should also address documented examples of weaknesses in internal management and administration, such as the absence of coordination between its diff erent departments and programmes; overabundance of doctors relative to nurses, social scientists, economists, lawyers, and political scientists; tolerance of underperforming senior executives; arcane bureaucratic procedures; and poor personnel management practices that have demoralised staff . 20, 21 An equally challenging set of barriers relate to WHO's operating environment. One such barrier is funding arrangements. WHO's core funding has remained static for many years and is currently inadequate, amounting to a tiny fraction of the health spending of high-income member states. Furthermore, more than two-thirds of WHO expenditure arises from conditional, extrabudgetary funds that are earmarked for specifi c projects by contributing countries and other donors. This system makes it diffi cult for WHO to plan and fund a coherent programme of work, and forces departments and divisions to compete with each other (and other organisations) and be susceptible to fragmented, donor-driven agendas.
As government contributions stagnate, WHO has been forced to rely on private sources of fi nancing and public-private partnerships. This reliance has resulted in a subtle erosion of public accountability and public-health principles to accommodate the interests and orientation of new donors. For example, the development of new medical technologies has become overemphasised in comparison with strengthening the capacity to deliver existing technologies and the more integrated sociodevelopmental approach of the primary health-care philosophy.
Budgetary control is one mechanism by which some actors constrain the performance of WHO. But there is also direct political pressure on WHO. For example, some member country delegations have warned WHO to steer clear of macroeconomics and trade issues and avoid reference to terminology such as "the right to health". As a result, WHO has taken a weak position on important economic issues. Its guide to the health implications of multilateral trade agreements was watered down following pressure from some governments and the World Trade Organization. 22 The USA forced WHO to sanction and recall an employee from Thailand for drawing attention to a negative aspect of the Free Trade Agreement between the USA and Thailand. 3 Another barrier is the multitude of global health initiatives and agencies with funding and governance arrangements that contribute to a chaotic operating environment for WHO. The time has come for a signifi cant rationalisation of the global health landscape. At least, developing country member states should lobby to capacitate WHO with the mandate and resources for a stewardship role in coordinating the work of offi cial donor agencies and global health initiatives.
Finally, a comment on the current state of global governance and the UN in general is necessary. According to the World Commission on the Social Dimensions of Globalisation, there are "serious problems with the current structure and processes of global governance". The propensity of some nation states to fl out international law and undermine the UN will make the task of the new Director-General harder. But it also makes the election of a new Director-General crucial because of the potential for WHO to act as a conduit towards a more eff ective and just system of global governance. The global health community, with its knowledge and understanding of the borderless nature of health threats, can play a vanguard part.
The right Director-General for the right manifesto
WHO already has a positive manifesto, embodied in its constitution and the Alma Ata Declaration-one that refl ects fairness, global solidarity, eff ective health care for all, public accountability, and a strong sociodevelopmental orientation. In recent decades this manifesto has been subverted.
The aspiration of health for all has been replaced by a tacit acceptance of growing health inequalities and the timid aim to provide a minimum package for the poor. Strong global health leadership capable of acting as a health conscience for the world has been replaced by a fragmented landscape of selective global health initiatives designed to mitigate the underlying determinants of health rather than to challenge them. The social dimensions of health systems that stand out in the Alma Ata Declaration and District Health Systems model have weakened in the face of a narrow, neoliberal conceptualisation of cost-eff ectiveness and an uncritical faith in market-based incentives.
To adopt a bolder, broader, and more progressive public-health agenda, WHO will need charismatic, wise, and courageous leadership. The hundreds of millions of people with the least access to health care deserve a Director-General capable of providing decisive intellectual leadership and withstanding political pressure.
To encourage a more transparent and democratic process for the fi nal selection of the Director-General, the People's Health Movement has asked all candidates to respond to a set of questions (panel), the responses to which it will then publish. The Movement will also compile profi les to facilitate a more public examination of the strengths and weaknesses of each candidate.
However, the fi nal selection will be the result of opaque power brokerage involving 34 members of the Executive Board. Behind closed doors, they will interview and then select from a shortlist. Structured criteria to assess the relative strengths and weaknesses of the candidates and how each individual scored will not be made public. This non-transparent process is unacceptable.
After the election, the People's Health Moverment will lobby to reform this process for future Director-General appointments. Civil society organisations could take other action to make WHO an organisation of the people as well as of governments. They could develop a joint initiative to monitor discussions, debates, and decisions at WHO Executive Board meetings. A stronger civil society presence at the meetings, coupled with a facility to report on proceedings, would improve transparency and scrutiny of policy development, and would create a counterweight to the propensity of some member states and other actors to bully WHO. The civil society initiative established under Brundtland could be revived to allow a wider range of voices to be heard and heeded, particularly those of marginalised and poor com munities.
Civil society could and should also prevail on governments and donors to improve the quantity and quality of funding to WHO. The formula for determining the level of contributions should be reviewed and a report card generated to rank countries according to amount of funding as well as the proportion of funding that is untied. Civil society should also demand that the amount, nature, and conditionalities of any private sources of fi nancing be fully disclosed to the public.
The forthcoming election marks a crucial opportunity for WHO, and a critical juncture at which to examine global-health governance more broadly. We hope that the new Director-General will enable WHO to catalyse a radical and progressive public-health agenda fundamental to improving the health of the world's poor.
